[1]
|
Ferlay, J., Parkin, D.M. and Steliarova-Foucher, E. (2010) Estimates of Cancer Incidence and Mortality in Europe in 2008. European Journal of Cancer, 46, 765-781. http://dx.doi.org/10.1016/j.ejca.2009.12.014
|
[2]
|
Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300. http://dx.doi.org/10.3322/caac.20073
|
[3]
|
Bostwick, D.G., Burke, H.B., Djakiew, D., Euling, S., Ho, S.M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D.J. and Timms, B. (2004) Human Prostate Cancer Risk Factors. Cancer, 101, 2371-2490. http://dx.doi.org/10.1002/cncr.20408
|
[4]
|
Joseph, P. and Jaiswal, A.K. (1994) Nad(p)h:Quinone Oxidoreductase1 (dt Diaphorase) Specifically Prevents the Formation of Benzo[a]Pyrene Quinone-DNA Adducts Generated by Cytochrome p4501a1 and p450 Reductase. Proceedings of the National Academy of Sciences of the United States of America, 91, 8413-8417. http://dx.doi.org/10.1073/pnas.91.18.8413
|
[5]
|
Jaiswal, A.K., McBride, O.W., Adesnik, M. and Nebert, D.W. (1988) Human Dioxin-Inducible Cytosolic nad(p)h: Menadione Oxidoreductase. Cdna Sequence and Localization of Gene to Chromosome 16. Journal of Biological Chemistry, 263, 13572-13578.
|
[6]
|
Traver, R.D., Siegel, D., Beall, H.D., Phillips, R.M., Gibson, N.W., Franklin, W.A. and Ross, D. (1997) Characterization of a Polymorphism in nad(p)h:Quinone Oxidoreductase (dt-Diaphorase). British Journal of Cancer, 75, 69-75. http://dx.doi.org/10.1038/bjc.1997.11
|
[7]
|
Steinbrecher, A., Rohrmann, S., Timofeeva, M., Risch, A., Jansen, E. and Linseisen, J. (2010) Dietary Glucosinolate Intake, Polymorphisms in Selected Biotransformation Enzymes, and Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention, 19, 135-143. http://dx.doi.org/10.1158/1055-9965.EPI-09-0660
|
[8]
|
Mandal, R.K., Nissar, K. and Mittal, R.D. (2012) Genetic Variants in Metabolizing Genes nqo1, nqo2, mthfr and Risk of Prostate Cancer: A Study from North India. Molecular Biology Reports, 39, 11145-11152. http://dx.doi.org/10.1007/s11033-012-2023-z
|
[9]
|
Stoehr, C.G., Nolte, E., Wach, S., Wieland, W.F., Hofstaedter, F., Hartmann, A. and Stoehr, R. (2012) Nad(p)h: Quinone Oxidoreductase 1 (nqo1) p187s Polymorphism and Prostate Cancer Risk in Caucasians. International Journal of Molecular Sciences, 13, 10959-10969. http://dx.doi.org/10.3390/ijms130910959
|
[10]
|
Ergen, H.A., Gormus, U., Narter, F., Zeybek, U., Bulgurcuoglu, S. and Isbir, T. (2007) Investigation of nad(p)h: Quinone Oxidoreductase 1 (nqo1) c609t Polymorphism in Prostate Cancer. Anticancer Research, 27, 4107-4110.
|
[11]
|
Hamajima, N., Matsuo, K., Iwata, H., Shinoda, M., Yamamura, Y., Kato, T., Hatooka, S., Mitsudomi, T., Suyama, M., Kagami, Y., Ogura, M., Ando, M., Sugimura, Y. and Tajima, K. (2002) NAD(P)H:Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism and the Risk of Eight Cancers for Japanese. International Journal of Clinical Oncology, 7, 103-108.
|
[12]
|
Steiner, M., Hillenbrand, M., Borkowsi, M., Seiter, H. and Schuff-Werner, P. (1999) 606 C→T Polymorphism in NAD(P)H:Quinone Oxidoreductase Gene in Patients with Prostatic Adenocarcinoma or Benign Prostatic Hyperplasia. Cancer Letters, 135, 67-71. http://dx.doi.org/10.1016/S0304-3835(98)00269-9
|
[13]
|
Mantel, N. and Haenszel, W. (1959) Statistical Aspects of the Analysis of Data from Retrospective Studies of Disease. Journal of the National Cancer Institute, 22, 719-748.
|
[14]
|
Der Simonian, R. and Laird, N. (1986) Meta-Analysis in Clinical Trials. Controlled Clinical Trials, 7, 177-188. http://dx.doi.org/10.1016/0197-2456(86)90046-2
|
[15]
|
Asher, G., Lotem, J., Cohen, B., Sachs, L. and Shaul, Y. (2001) Regulation of p53 Stability and p53-Dependent Apoptosis by NADH Quinone Oxidoreductase 1. Proceedings of the National Academy of Sciences of the United States of America, 98, 1188-1193. http://dx.doi.org/10.1073/pnas.98.3.1188
|
[16]
|
Anwar, A., Dehn, D., Siegel, D., Kepa, J.K., Tang, L.J., Pietenpol, J.A. and Ross, D. (2003) Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-Free Systems. Journal of Biological Chemistry, 278, 10368-10373. http://dx.doi.org/10.1074/jbc.M211981200
|
[17]
|
Long, D.J., Waikel, R.L., Wang, X.J., Perlaky, L., Roop, D.R. and Jaiswal, A.K. (2000) NAD(P)H:Quinone Oxidoreductase 1 Deficiency Increases Susceptibility to Benzo(a)pyrene-Induced Mouse Skin Carcinogenesis. Cancer Research, 60, 5913-5915.
|
[18]
|
Iskander, K., Gaikwad, A., Paquet, M., Long, D.J., Brayton, C., Barrios, R. and Jaiswal, A.K. (2005) Lower Induction of p53 and Decreased Apoptosis in NQO1-Null Mice Lead to Increased Sensitivity to Chemical-Induced Skin Carcinogenesis. Cancer Research, 65, 2054-2058. http://dx.doi.org/10.1158/0008-5472.CAN-04-3157
|
[19]
|
Siegel, D., Gustafson, D.L., Dehn, D.L., Han, J.Y., Boonchoong, P., Berliner, L.J. and Ross, D. (2004) NAD(P)H: Quinone Oxidoreductase 1: Role as a Superoxide Scavenger. Molecular Pharmacology, 65, 1238-1247. http://dx.doi.org/10.1124/mol.65.5.1238
|
[20]
|
Dinkova-Kostova, A.T. and Talalay, P. (2010) NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1), a Multifunctional Antioxidant Enzyme and Exceptionally Versatile Cytoprotector. Archives of Biochemistry and Biophysics, 501, 116-123. http://dx.doi.org/10.1016/j.abb.2010.03.019
|
[21]
|
Egger, M., Smith, G.D. and Phillips, A.N. (1997) Meta-Analysis: Principles and Procedures. BMJ, 315, 1533-1537. http://dx.doi.org/10.1136/bmj.315.7121.1533
|
[22]
|
Li, D., Liu, J., Zhang, W., Ren, J., Yan, L., Liu, H. and Xu, Z. (2013) Association between HIF1A P582S and A588T Polymorphisms and the Risk of Urinary Cancers: A Meta-Analysis. PLoS ONE, 8, e63445. http://dx.doi.org/10.1371/journal.pone.0063445
|
[23]
|
Li, D., Liu, H., Yan, L., Tang, Y., Ren, J. and Xu, Z. (2012) Lack of Association between Hogg1 Ser326Cys Polymorphism and the Risk of Bladder Cancer: A Meta-Analysis. Urologia Internationalis, 88, 88-94. http://dx.doi.org/10.1159/000331931
|
[24]
|
Li, D., Tian, T., Guo, C., Ren, J., Yan, L., Liu, H. and Xu, Z. (2012) No Association of the MTHFR Gene A1298C Polymorphism with the Risk of Prostate Cancer: A Meta-Analysis. Experimental and Therapeutic Medicine, 3, 493-498.
|
[25]
|
Liu, K., Tian, H., Yu, K.Z., Shen, W.Y., Mao, Z.C., Jin, C.H., Pan, H.B. and He, J.X. (2013) Association between NQO1 Pro187Ser Polymorphism and Esophageal Cancer: A Meta-Analysis. Tumor Biology, 35, 2063-2068.
|
[26]
|
Zhao, H., Zhu, F., Sun, J. and Meng, X. (2013) Meta-Analysis of the Association between NQO1 Pro187Ser Polymorphism and Colorectal Cancer in Asians. Tumor Biology, 35, 2111-2116. http://dx.doi.org/10.1007/s13277-013-0740-0
|
[27]
|
Zhang, H., Wen, X. and Lu, X. (2013) Association between NAD(P)H:Quinone Oxidoreductase 1 rs1800566 Polymorphism and Risk of Bladder Cancer. Tumor Biology, 34, 3377-3381. http://dx.doi.org/10.1007/s13277-012-0633-7
|
[28]
|
Lajin, B. and Alachkar, A. (2013) The NQO1 Polymorphism C609T (Pro187Ser) and Cancer Susceptibility: A Comprehensive Meta-Analysis. British Journal of Cancer, 109, 1325-1337. http://dx.doi.org/10.1038/bjc.2013.357
|
[29]
|
Thakkinstian, A., McElduff, P., D’Este, C., Duffy, D. and Attia, J. (2005) A Method for Meta-Analysis of Molecular Association Studies. Statistics in Medicine, 24, 1291-1306. http://dx.doi.org/10.1002/sim.2010
|
[30]
|
Eickelmann, P., Schulz, W.A., Rohde, D., Schmitz-Drager, B. and Sies, H. (1994) Loss of Heterozygosity at the NAD(P)H:Quinone Oxidoreductase Locus Associated with Increased Resistance against Mitomycin C in a Human Bladder Carcinoma Cell Line. Biological Chemistry Hoppe-Seyler, 375, 439-445. http://dx.doi.org/10.1515/bchm3.1994.375.7.439
|
[31]
|
Siegel, D., Anwar, A., Winski, S.L., Kepa, J.K., Zolman, K.L. and Ross, D. (2001) Rapid Polyubiquitination and Proteasomal Degradation of a Mutant Form of NAD(P)H:Quinone Oxidoreductase 1. Molecular Pharmacology, 59, 263-268.
|
[32]
|
Siegel, D., McGuinness, S.M., Winski, S.L. and Ross, D. (1999) Genotype-Phenotype Relationships in Studies of a Polymorphism in NAD(P)H:Quinone Oxidoreductase 1. Pharmacogenetics, 9, 113-121. http://dx.doi.org/10.1097/00008571-199902000-00015
|
[33]
|
Misra, V., Grondin, A., Klamut, H.J. and Rauth, A.M. (2000) Assessment of the Relationship between Genotypic Status of a DT-Diaphorase Point Mutation and Enzymatic Activity. British Journal of Cancer, 83, 998-1002. http://dx.doi.org/10.1054/bjoc.2000.1359
|
[34]
|
Hajos, A.K. and Winston, G.W. (1991) Purified NAD(P)H-Quinone Oxidoreductase Enhances the Mutagenicity of Dinitropyrenes in Vitro. Journal of Biochemical Toxicology, 6, 277-282. http://dx.doi.org/10.1002/jbt.2570060407
|